Perbak Capital Partners’s Omega Healthcare OHI Stock Holding History

Perbak Capital Partners’s Portfolio OHI Stock Details OHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-21,424	Closed	-$939K	–	171
2026 Q1	$939K	Buy	+21,424	New	+$978K	0.23%	80

Other funds holding OHI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Cohen & Steers New York $63.2B AUM 17.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Perbak Capital Partners's OHI Position: Q2 2026 in Review

Perbak Capital Partners sold out of Omega Healthcare (OHI) in Q2 2026, closing a stake of 21,424 shares — an estimated $939K sold.

Perbak Capital Partners first reported a position in OHI in Q1 2026 and held it in 1 quarter. The position peaked at $939K in Q1 2026. 761 funds tracked by Wall St. Rank hold OHI as of Q2 2026.

Perbak Capital Partners reported no remaining Omega Healthcare position as of Q2 2026 after selling out during the quarter.
Perbak Capital Partners sold 21,424 Omega Healthcare shares in Q2 2026, an estimated $939K.
Perbak Capital Partners first reported a position in Omega Healthcare in Q1 2026 and held it in 1 quarter.
Perbak Capital Partners's Omega Healthcare position peaked at $939K in Q1 2026.
761 funds tracked by Wall St. Rank held Omega Healthcare as of Q2 2026.

Based on Perbak Capital Partners's 13F filing for Q2 2026.